ARCHIVES

Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | November 25, 2011

Download PDF Visit The Full Archive

Related Articles

ONS Annual Meeting To Highlight Nursing Progress In ‘70s, ‘80s

April 20, 1990

NCI May Ask Grantees To Assume Additional Services, Broder Says

November 11, 1994

New Agents, New Approaches Benefit Treatment Of Advanced Lung Cancer

August 29, 2003

AACI To Seek Line Item For Centers In Cancer Act Renewal

January 18, 1980

Illinois Congressman Calls For Full Bypass Budget Appropriation In cancer Prevention – $180 Million

February 22, 1991

DeVita Distressed Over “Misinformation” Circulation On Organ Systems Program

April 8, 1983